Quotient (NASDAQ:QTNT) reported quarterly sales of $9.79 million which beat the analyst consensus estimate of $8.17 million by 19.78 percent. This is a 1.54 percent increase over sales of $9.64 million the same period last year.
Stifel Upgrades Glaukos to Buy, Raises Price Target to $60
Stifel analyst Thomas Stephan upgrades Glaukos (NYSE:GKOS) from Hold to Buy and raises the price target from $40 to $60.